Citation: M. Misoph et al., RESPONSE OF THE CELLULAR IMMUNE-SYSTEM TO CARDIOPULMONARY BYPASS IS INDEPENDENT OF THE APPLIED PUMP TYPE AND OF THE USE OF HEPARIN-COATED SURFACES, The thoracic and cardiovascular surgeon, 46(4), 1998, pp. 222-227
Authors:
STEINBRUECKNER B
STEIGERWALD U
KELLER F
ORDUNG R
NEUENROTH L
REUTHER J
KLINKER H
SCHWENDER S
Citation: B. Steinbrueckner et al., ATYPICAL SPONTANEOUS FACTOR-VIII INHIBITOR - SPECIFIC DIAGNOSTICS ANDTHERAPY OF ACUTE BLEEDING, Acta haematologica, 99(2), 1998, pp. 102-105
Authors:
SCHAMBECK CM
GROSSMANN R
HAUBITZ I
SCHEUER H
SCHMITT R
SCHWAB J
SCHWENDER S
SPENGLER A
KELLER F
Citation: Cm. Schambeck et al., ENHANCED RISK OF VENOUS THROMBOEMBOLISM IN FACTOR-V-LEIDEN CARRIERS ON ORAL-CONTRACEPTIVE USE - RATIONALE FOR A LIMITED SCREENING FOR THE MUTATION, Thrombosis and haemostasis, 1997, pp. 1260-1260
Authors:
GROSSMANN R
SCHWENDER S
MANSOURITALEGHANI B
WIEBECKE D
KELLER F
Citation: R. Grossmann et al., TREATMENT OF A FACTOR-VIII AUTOANTIBODY WITH LONG-TERM IGG-IMMUNOADSORPTION AND IMMUNOSUPPRESSION, Thrombosis and haemostasis, 1997, pp. 2646-2646
Authors:
SCHAMBECK CM
SCHWENDER S
HAUBITZ I
GEISEN UE
GROSSMANN RE
KELLER F
Citation: Cm. Schambeck et al., SELECTIVE SCREENING FOR THE FACTOR-V-LEIDEN MUTATION - IS IT ADVISABLE PRIOR TO THE PRESCRIPTION OF ORAL-CONTRACEPTIVES, Thrombosis and haemostasis, 78(6), 1997, pp. 1480-1483
Citation: M. Misoph et al., A COMPARATIVE-EVALUATION OF THE EFFECT OF PUMP TYPE AND HEPARIN-COATED SURFACES ON PLATELETS DURING CARDIOPULMONARY BYPASS, The thoracic and cardiovascular surgeon, 45(6), 1997, pp. 302-306
Authors:
MISOPH M
BABINEBELL J
SCHWENDER S
GROSSMANN R
KELLER F
ELERT O
Citation: M. Misoph et al., RESPONSE OF THE CELLULAR IMMUNE-SYSTEM TO CARDIOPULMONARY BYPASS IN-VIVO, The thoracic and cardiovascular surgeon, 45(5), 1997, pp. 217-223
Authors:
GROSSMANN R
WANKMULLER H
SCHWENDER S
KIRSCHNER J
MANSOURITALEGHANI B
KELLER F
KOCHSIEK K
Citation: R. Grossmann et al., DIAGNOSIS AND TREATMENT OF AN ACQUIRED FA CTOR-VIII INHIBITOR IN COMBINATION WITH LUPUS ANTICOAGULANTS, Deutsche Medizinische Wochenschrift, 121(28-29), 1996, pp. 906-910
Authors:
GROSSMANN R
EBELL JB
MISOPH M
SCHWENDER S
NEUKAM K
HICKETHIER T
ELERT O
KELLER F
Citation: R. Grossmann et al., CHANGES IN COAGULATION AND FIBRINOLYTIC PARAMETERS CAUSED BY EXTRACORPOREAL-CIRCULATION, Heart and vessels, 11(6), 1996, pp. 310-317
Citation: H. Wankmuller et al., APC RESISTANCE - PATHOGENESIS, DIAGNOSIS, PREVALENCE AND SIGNIFICANCEOF A NEW RISK FACTOR FOR THROMBOSIS, Medizinische Klinik, 91(5), 1996, pp. 308
Authors:
HEIN A
SCHWENDER S
IMRICH H
SOPPER S
CZUB M
DORRIES R
Citation: A. Hein et al., PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION OF CD8(-LYMPHOCYTES FROM THE CENTRAL-NERVOUS-SYSTEM OF RATS WITH CORONAVIRUS JHM INDUCED DEMYELINATING ENCEPHALOMYELITIS() T), Journal of neurovirology, 1(5-6), 1995, pp. 340-348
Citation: S. Schwender et al., DETECTION OF AUTOANTIBODIES TO VON-WILLEBRAND-FACTOR USING A WESTERN-BLOT SYSTEM, Thrombosis and haemostasis, 73(6), 1995, pp. 1175-1175
Authors:
CZUB M
CZUB S
RAPPOLD M
MAZGAREANU S
SCHWENDER S
DEMUTH M
HEIN A
DORRIES R
Citation: M. Czub et al., MURINE LEUKEMIA VIRUS-INDUCED NEURODEGENERATION OF RATS - ENHANCEMENTOF NEUROPATHOGENICITY CORRELATES WITH ENHANCED VIRAL TROPISM FOR MACROPHAGES, MICROGLIA, AND BRAIN VASCULAR CELLS, Virology, 214(1), 1995, pp. 239-244
Citation: H. Imrich et al., CERVICAL LYMPHOID-TISSUE BUT NOT THE CENTRAL-NERVOUS-SYSTEM SUPPORTS PROLIFERATION OF VIRUS-SPECIFIC T-LYMPHOCYTES DURING CORONAVIRUS-INDUCED ENCEPHALITIS IN RATS, Journal of neuroimmunology, 53(1), 1994, pp. 73-81
Authors:
DORRIES R
IMRICH H
HEIN A
CZUB S
SCHWENDER S
Citation: R. Dorries et al., THE IMPACT OF THE INTRACEREBRAL ANTIBODY-RESPONSE ON THE CLINICAL COURSE OF A VIRUS-INDUCED DEMYELINATION IN A RAT MODEL SYSTEM, Journal of Neurology, Neurosurgery and Psychiatry, 57, 1994, pp. 18-20